Increasing incidences of infectious diseases and the rise in the number of blood donations is expected to drive the market for blood screening.
Market Size – USD 1.87 Billion in 2019
Market Growth – CAGR of 12.7%
Market trends – Growing prevalence of new pathogens.
The Blood Screening Market is estimated to be worth USD 4.86 Billion by the year 2027. Increasing cases of several infectious diseases, growing awareness regarding healthcare, steady growth in the blood donations number, and surging nucleic acid amplification test (NAT) are a few primary factors propelling the growth of the industry.
Moreover, advancements in technology and increasing government support towards developing an advanced healthcare system are further contributing to the industry’s growth. Another crucial factor is majorly fueling the growth of the blood screening market including increasing rate of technological development in the area of healthcare. Surging demand for different advanced methods in the area of sample preparation, extraction, amplification, and testing for distinct nucleic acids such as DNA and RNA, and strategic collaboration of market manufacturers with popular research institutions are encouraging various research activities. All these factors are also positively impacting the growth of the overall industry.
Geographically, the region of North America has accounted for the maximum industry share, due to the rising blood tests’ prominence, and growing activities of R&D in the region. Presence of well-equipped and established healthcare organizations, rising government efforts to promote the usage of disposable blood bags, and continuous development in the aspects of sterility are also promoting growth of this regional market.
The market for blood screening has observed an exponential rise, due to the presence of frontline biopharmaceutical innovators during the global human response to the COVID-19 pandemic. Several biotech firms are operating in the middle of the race for investigating the virus’s genome, developing a viable vaccine. Various private and public sectors are working continuously in order to manufacture the vaccine. Surging demand for different testing kits in the Sars-Cov-2 diagnosis is further creating a demand in the industry.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/blood-screening-market
Further key findings from the report suggest
- The segment of reagent and kits held a significant industry share, due to the high accessibility of a variety of reagents and the demand for reliable, specific, and rapid detection of blood screening. Soaring demand for blood transfusion required in the treatment of various blood disorders contributed largely to the industry demand.
- NAT—a molecular method deployed in the activities of blood donation for screening the blood, decreasing the threat of transfusion-transmitted infections among the individuals receiving the blood.
- The segment of hospitals accounted for the maximum industry share owing to the increasing number of recorded cases.
- Key players include Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories, Inc., Dickinson and Company, Becton, Ortho-Clinical Diagnostics, Inc., F. Hoffmann-La Roche Ltd., Grifols, SOFINA S.A, Thermo Fisher Scientific, Inc., and Siemens Healthcare GmbH.
For the purpose of this report, Reports And Data has segmented the Global Blood Screening Market on the basis of product and services, technology, end-user, and region:
Product and Services Outlook (Revenue, USD Billion; 2017-2027)
- Reagents and Kits
- NAT Reagents and Kits
- Standards and Controls
- Buffers, Nucleotides, and Solutions
- Enzymes and Polymerases
- Probes and Primers
- Labeling and Detection Reagents
- ELISA Reagents and Kits
- Controls
- Substrates
- Immunosorbents
- Conjugates
- Sample Diluents and Wash Solutions
- Instruments
- Rental Purchase
- Outright Purchase
- Software and Services
Technology Outlook (Revenue, USD Billion; 2017-2027)
- ELISA
- Fluorescent immunoassay
- Chemiluminescent Immunoassay
- Colorimetric Immunoassay
- NAT
- Transcription-Mediated Amplification
- Real-time Polymerase Chain Reaction
- Western Blot Assays
- Rapid Tests
- NGS
End-User Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals
- Blood Banks
Get a FREE Report Sample with Table of Contents and Figures @ https://www.reportsanddata.com/sample-enquiry-form/3458
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- US.
- Canada
- Europe
- Germany
- UK.
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- Rest of MEA
Table of Contents
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Indicative Metrics
Chapter 4. Blood Screening Market Segmentation & Impact Analysis
4.1. Blood Screening Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing demand for donated blood and rising number of blood donations
4.2.2.2. Rising prevalence of infectious diseases
4.2.3. Market restraints analysis
4.2.3.1. High Cost
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter’s Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price trend Analysis
4.9. Customer Mapping
4.10. Covid-19 Impact Analysis
4.11. Global Recession Influence
Continued………
Ask for your specific company profile and country level customization on reports.
Liquid Embolic Market To Reach USD 3.27 Billion By 2027
Antibody Production Market To Reach USD 29.58 Billion By 2027
Surgical Navigation Systems Market To Reach USD 1.21 Billion by 2026
Therapeutic Obstructive Sleep Apnea Devices Market To Reach USD 6.22 Billion By 2026
X-ray Photoelectron Spectroscopy Market To Reach USD 952.34 Million By 2027
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
Head of Business Development
40 Wall St. 28th floor New York City
NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Facebook | LinkedIn | Twitter | Blogs
